Page 2 - Patanjali

Patanjali Foods down 11% in trade today; here's what's worrying investors

Around 10:35 AM, Patanjali share price was down 9.56 per cent at Rs 1,639.7 per share on BSE. In comparison, the BSE Sensex was down 1.19 per cent at 73,727.81

Best of BS Opinion: The many hats a government wears in citizens' lives

The undeniable thing is that government can shape the very nature of the nation, for better or for worse. From finances to health to labour to communication to awareness, it wields great power.

Big relief for Patanjali Foods as SC quashes Rs 186 crore tax demand

Earlier the NCLT had quashed the tax demands, leading the Income Tax Department to challenge it in the Bombay High Court, before escalating matter to the Supreme Court

Stocks to Watch, Feb 11: Nykaa, Berger Paints, Vi, Eicher Motors, GAIL

Stocks to Watch on February 11, 2025: From Nykaa to Berger Paints, here is a list of stocks that will be in focus today

Patanjali Foods Q3 results: Profit jumps 71% on cooking oil boost

Revenue from Patanjali's edible oils segment, which makes up nearly three-fourths of its total revenue, rose 22.5% during the quarter

Patanjali recalls 4 tonnes of red chilli powder over regulatory compliance

The development comes after the Food Safety and Standards Authority of India (FSSAI) issued an order to the company to recall an entire batch of the product

Fssai directs FMCG firm Patanjali to recall red chilli powder batch

In an exchange filing on Thursday, Patanjali stated it had received the order on January 16

Court issues bailable warrant against Ramdev, Balkrishna over misleading ad

A Kerala court has issued a bailable warrant against Patanjali's Ramdev and Balkrishna for publishing misleading ads, following a drug inspector's report on violations of advertising laws

Delhi HC seeks Patanjali stand on lawsuit by Dabur over 'disparaging' ad

The Delhi High Court has sought Patanjali Ayurved's stand on a lawsuit by Dabur over advertisements allegedly disparaging its product Chyawanprash. On December 24, Justice Mini Pushkarna issued summons on the lawsuit to the defendants -- Patanjali Ayurved and Patanjali Foods Ltd -- for a reply in the matter. "Accordingly, let the plaint be registered as suit. Issue summons.. Let the written statement be filed by the defendants within thirty days from today," the order said. Dabur alleged that while promoting Patanjali Special Chyawanprash, fallacious and deliberate imputations were made, which defamed its product Dabur Chyawanprash -- a market leader with a share of more than 60 per cent. The court also issued notice on an application seeking an interim relief and posted the hearing on January 30. The plea said in the advertisements, the defendants have claimed only Patanjali Special Chyawanprash was the "original" and therefore "special" besides being "shreshtham/sarv-shreshth" o

Dabur sues Patanjali Ayurved over 'disparaging' Chyawanprash advertisement

The lawsuit alleges that an advertisement featuring Patanjali Ayurved founder Baba Ramdev falsely claims that only Patanjali's Chyawanprash is 'original'

Patanjali Foods Q2 results: Net profit increases 21% to Rs 309 cr

The Ruchi Gold oil maker's profit rose to Rs 309 crore (about $37 million) for the three months ended Sept. 30, from Rs 255 crore a year earlier

India's edible oil demand to increase despite hefty import duty hike

India is the world's largest importer and meets 70% of its vegetable oil demand through foreign sourcing

Patanjali Foods drops 4% after large block deal; promoter grp likely seller

Patanjali Foods share price: Reports said Promoter entities Patanjali Ayurved, and Patanjali Parivahan were looking to sell up to 11 million shares in the company

HC asks for Centre's stand on plea over 'misbranding' of Patanjali product

The Delhi High Court on Friday sought the Centre's stand on a petition seeking action against the alleged misbranding of Patanjali's "Divya Dant Manjan" as a vegetarian product. The petitioner's counsel claimed that though the dental care product was being sold with a "green dot", symbolising that it was a vegetarian commodity, it contains fish extract, a non-vegetarian ingredient. Justice Sanjeev Narula issued notice to the Centre, the Food Safety and Standards Authority of India (FSSAI) as well as Patanjali, Divya Pharmacy, Yoga guru Ramdev and other related parties on the petition by lawyer Yatin Sharma. The law does not mandate declaration of a "drug" as vegetarian or non-vegetarian but the packaging of "Divya Dant Manjan" wrongly carries a "green dot", which qualifies as "misbranding" under the Drugs and Cosmetics Act, the petitioner's counsel argued. The matter would be heard next in November. Represented by advocates Swapnil Chaudhary and Prashant Gupta, the petitioner stat

SC stays Ayush Ministry's notification in Patanjali misleading ads case

'Rule 170 of Drugs and Cosmetic Rules 1945, which deals with prohibition of misleading advertisement of Ayurveda, Siddha or Unani drugs, shall remain in the statute book'

Buy & Sell Ideas for Aug 12; top two picks by Rajesh Bhosale of Angel One

On the weekly chart, Patanjali has previously faced notable resistance near the Rs 1,700 level. However, despite challenging market conditions this week, the stock has experienced a significant break

Patanjali case: SC orders IMA President to publish apology using own money

Patanjali misleading ads case: The Supreme Court ordered IMA President RV Asokan to issue apology in leading newspapers and to cover its cost himself

Patanjali stock hits new high, up 7% on hopes of higher rural demand

With a strong presence in the hinterland, Patanjali Foods is positive about rural demand moving northwards in the coming quarter.

SC asks Uttarakhand govt to decide on suspension of 14 Patanjali products

Licences for 14 Ayurvedic products by Patanjali and Divya Pharmacy were suspended by the Uttarakhand government. However, on July 1, the state government revoked its suspension order

Take down tweets defaming allopathy: Delhi HC to Patanjali Ayurved

Court says disparaging claims undermine ayurveda's credibility